share_log

Stifel Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $6

Stifel Downgrades Treace Medical Concepts to Hold, Lowers Price Target to $6

Stifel將Treace Medical Concepts的評級下調至持有,將目標股價下調至6美元
Benzinga ·  05/08 06:26

Stifel analyst Rick Wise downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Hold and lowers the price target from $15 to $6.

Stifel分析師裏克·懷斯將Treace Medical Concepts(納斯達克股票代碼:TMCI)的評級從買入下調至持有,並將目標股價從15美元下調至6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論